Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ALPHA-SYNUCLEIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 400 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kanazawa, I
      How do neurons die in neurodegenerative diseases?

      TRENDS IN MOLECULAR MEDICINE
    2. McNaught, KSP; Olanow, CW; Halliwell, B; Isacson, O; Jenner, P
      Failure of the ubiquitin-proteasome system in Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    3. Beal, MF
      Experimental models of Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    4. Goedert, M
      Parkinson's disease and other alpha-synucleinopathies

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    5. Matsubara, M; Yamagata, H; Kamino, K; Nomura, T; Kohara, K; Kondo, I; Miki, T
      Genetic association between Alzheimer disease and the alpha-synuclein gene

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    6. Stoessl, AJ
      Antisense strategies for the treatment of neurological disease

      EXPERT OPINION ON THERAPEUTIC PATENTS
    7. Satoh, JI; Kuroda, Y
      Alpha-synuclein expression is up-regulated in NTera2 cells during neuronaldifferentiation but unaffected by exposure to cytokines and neurotrophic factors

      PARKINSONISM & RELATED DISORDERS
    8. Pal, PK; Wszolek, ZK; Uitti, R; Markopoulou, K; Calne, SM; Stoessl, AJ; Calne, DB
      Positron emission tomography of dopamine pathways in familial Parkinsoniansyndromes

      PARKINSONISM & RELATED DISORDERS
    9. Trojanowski, JQ; Lee, VMY
      Parkinson's disease and related neurodegenerative synucleinopathies linkedto progressive accumulations of synuclein aggregates in brain

      PARKINSONISM & RELATED DISORDERS
    10. Swerdlow, RH; Parker, WD; Currie, LJ; Bennett, JP; Harrison, MB; Trugman, JM; Wooten, GF
      Gender ratio differences between Parkinson's disease patients and their affected relatives

      PARKINSONISM & RELATED DISORDERS
    11. Dickson, DW
      alpha-Synuclein and the Lewy body disorders

      CURRENT OPINION IN NEUROLOGY
    12. Mizuno, Y; Hattori, N; Mori, H; Suzuki, T; Tanaka, K
      Parkin and Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    13. Chung, KKK; Zhang, Y; Lim, KL; Tanaka, Y; Huang, H; Gao, J; Ross, CA; Dawson, VL; Dawson, TM
      Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1:implications for Lewy-body formation in Parkinson disease

      NATURE MEDICINE
    14. Richter-Landsberg, C
      Organization and functional roles of the cytoskeleton in oligodendrocytes

      MICROSCOPY RESEARCH AND TECHNIQUE
    15. West, AB; Zimprich, A; Lockhart, PJ; Farrer, M; Singleton, A; Holtom, B; Lincoln, S; Hofer, A; Hill, L; Muller-Myhsok, B; Wszolek, ZK; Hardy, J; Gasser, T
      Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes

      EUROPEAN JOURNAL OF HUMAN GENETICS
    16. Hu, HY
      Abnormal protein aggregation and neurodegenerative diseases

      CHINESE SCIENCE BULLETIN
    17. Farrer, M; Destee, A; Levecque, C; Singleton, A; Engelender, S; Becquet, E; Mouroux, V; Richard, F; Defebvre, L; Crook, R; Hernandez, D; Ross, CA; Hardy, J; Amouyel, P; Chartier-Harlin, MC
      Genetic analysis of synphilin-1 in familial Parkinson's disease

      NEUROBIOLOGY OF DISEASE
    18. Goedert, M; Spillantini, MG; Serpell, LC; Berriman, J; Smith, MJ; Jakes, R; Crowther, RA
      From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    19. Morar, AS; Olteanu, A; Young, GB; Pielak, GJ
      Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c

      PROTEIN SCIENCE
    20. Tanji, K; Imaizumi, T; Yoshida, H; Mori, F; Yoshimoto, M; Satoh, K; Wakabayashi, K
      Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1 beta

      NEUROREPORT
    21. Hartman, VN; Miller, MA; Clayton, DF; Liu, WC; Kroodsma, DE; Brenowitz, EA
      Testosterone regulates alpha-synuclein mRNA in the avian song system

      NEUROREPORT
    22. Tanji, K; Mori, F; Nakajo, S; Imaizumi, T; Yoshida, H; Hirabayashi, T; Yoshimoto, M; Satoh, K; Takahashi, H; Wakabayashi, K
      Expression of beta-synuclein in normal human astrocytes

      NEUROREPORT
    23. Yip, CM
      Atomic force microscopy of macromolecular interactions

      CURRENT OPINION IN STRUCTURAL BIOLOGY
    24. Tanaka, K; Suzuki, T; Chiba, T; Shimura, H; Hattori, N; Mizuno, Y
      Parkin is linked to the ubiquitin pathway

      JOURNAL OF MOLECULAR MEDICINE-JMM
    25. Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E
      beta-synuclein inhibits alpha-synuclein aggregation: A possible role as ananti-parkinsonian factor

      NEURON
    26. Sherman, MY; Goldberg, AL
      Cellular defenses against unfolded proteins: A cell biologist thinks aboutneurodegenerative diseases

      NEURON
    27. Kotzbauer, PT; Trojanowski, JQ; Lee, VMY
      Lewy body pathology in Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    28. Turnbull, S; Tabner, BJ; El-Agnaf, OMA; Moore, S; Davies, Y; Allsop, D
      alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro

      FREE RADICAL BIOLOGY AND MEDICINE
    29. Surguchov, A; Palazzo, RE; Surgucheva, I
      Gamma synuclein: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction

      CELL MOTILITY AND THE CYTOSKELETON
    30. Simard, M; van Reekum, R
      Dementia with lewy bodies in Down's syndrome

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    31. Bostantjopoulou, S; Katsarou, Z; Papadimitriou, A; Veletza, V; Hatzigeorgiou, G; Lees, A
      Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation

      MOVEMENT DISORDERS
    32. Pastor, P; Munoz, E; Ezquerra, M; Obach, V; Marti, MJ; Valldeoriola, F; Tolosa, E; Oliva, R
      Analysis of the coding and the 5 ' flanking regions of the alpha-synucleingene in patients with Parkinson's disease

      MOVEMENT DISORDERS
    33. Boeve, BF; Silber, MH; Ferman, TJ; Lucas, JA; Parisi, JE
      Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy

      MOVEMENT DISORDERS
    34. Golbe, LI; Lazzarini, AM; Spychala, JR; Johnson, WG; Stenroos, ES; Mark, MH; Sage, JI
      The tau A0 allele in Parkinson's disease

      MOVEMENT DISORDERS
    35. Henderson, JM; Gai, WP; Hely, MA; Reid, WGJ; Walker, GL; Halliday, GM
      Parkinson's disease with late Pick's dementia

      MOVEMENT DISORDERS
    36. Dickson, DW
      Neuropathology of Alzheimer's disease and other dementias

      CLINICS IN GERIATRIC MEDICINE
    37. Siderowf, A
      Parkinson's disease - Clinical features, epidemiology, and genetics

      NEUROLOGIC CLINICS
    38. Mark, MH
      Lumping and splitting the Parkinson plus syndromes - Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration

      NEUROLOGIC CLINICS
    39. Hilker, R; Klein, C; Ghaemi, M; Kis, B; Strotmann, T; Ozelius, LJ; Lenz, O; Vieregge, P; Herholz, K; Heiss, WD; Pramstaller, PP
      Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene

      ANNALS OF NEUROLOGY
    40. Stefanova, N; Klimaschewski, L; Poewe, W; Wenning, GK; Reindl, M
      Glial cell death induced by overexpression of alpha-synuclein

      JOURNAL OF NEUROSCIENCE RESEARCH
    41. Surguchov, A; McMahan, B; Masliah, E; Surgucheva, I
      Synucleins in ocular tissues

      JOURNAL OF NEUROSCIENCE RESEARCH
    42. Gasser, T
      Genetics of Parkinson's disease

      JOURNAL OF NEUROLOGY
    43. Petroske, E; Meredith, GE; Callen, S; Totterdell, S; Lau, YS
      Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment

      NEUROSCIENCE
    44. McLean, PJ; Kawamata, H; Hyman, BT
      alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons

      NEUROSCIENCE
    45. Hishikawa, N; Hashizume, Y; Yoshida, M; Sobue, G
      Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    46. Parkkinen, L; Soininen, H; Laakso, M; Alafuzoff, I
      alpha-Synuclein pathology is highly dependent on the case selection

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    47. Layfield, R; Alban, A; Mayer, RJ; Lowe, J
      The ubiquitin protein catabolic disorders

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    48. Brat, DJ; Gearing, M; Goldthwaite, PT; Wainer, BH; Burger, PC
      Tau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    49. Kruger, R; Schols, L; Muller, T; Kuhn, W; Woitalla, D; Przuntek, H; Epplen, JT; Riess, O
      Evaluation of the gamma-synuclein gene in German Parkinson's disease patients

      NEUROSCIENCE LETTERS
    50. Bandopadhyay, R; de Silva, R; Khan, N; Graham, E; Vaughan, J; Engelender, S; Ross, C; Morris, H; Morris, C; Wood, NW; Daniel, S; Lees, A
      No pathogenic mutations in the synphilin-1 gene in Parkinson's disease

      NEUROSCIENCE LETTERS
    51. D'Andrea, MR; Ilyin, S; Plata-Salaman, CR
      Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues

      NEUROSCIENCE LETTERS
    52. Tan, EK; Nagamitsu, S; Matsuura, T; Khajavi, M; Jankovic, J; Ondo, W; Ashizawa, T
      Alcohol dehydrogenase polymorphism and Parkinson's disease

      NEUROSCIENCE LETTERS
    53. Izumi, Y; Morino, H; Oda, M; Maruyama, H; Udaka, F; Kameyama, M; Nakamura, S; Kawakami, H
      Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan

      NEUROSCIENCE LETTERS
    54. McNaught, KSP; Jenner, P
      Proteasomal function is impaired in substantia nigra in Parkinson's disease

      NEUROSCIENCE LETTERS
    55. Sopher, BL; Koszdin, KL; McClain, ME; Myrick, SB; Martinez, RA; Smith, AC; La Spada, AR
      Genomic organization, chromosome location, and expression analysis of mouse beta-synuclein, a candidate for involvement in neurodegeneration

      CYTOGENETICS AND CELL GENETICS
    56. Levecque, C; Destee, A; Mouroux, V; Becquet, E; Defebvre, L; Amouyel, P; Chartier-Harlin, MC
      No genetic association of the Ubiquitin Carboxy-terminal Hydrolase-L1 geneS18Y polymorphism with familial Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    57. Wenning, GK; Seppi, K; Scherfler, C; Stefanova, N; Puschban, Z
      Multiple system atrophy

      SEMINARS IN NEUROLOGY
    58. Simon, HH; Saueressig, H; Wurst, W; Goulding, MD; O'Leary, DDM
      Fate of midbrain dopaminergic neurons controlled by the engrailed genes

      JOURNAL OF NEUROSCIENCE
    59. Paxinou, E; Chen, QP; Weisse, M; Giasson, BI; Norris, EH; Rueter, SM; Trojanowski, JQ; Lee, VMY; Ishciropoulos, H
      Induction of alpha-synuclein aggregation by intracellular nitrative insult

      JOURNAL OF NEUROSCIENCE
    60. Ishihara, T; Higuchi, M; Zhang, B; Yoshiyama, Y; Hong, M; Trojanowski, JQ; Lee, VMY
      Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments

      JOURNAL OF NEUROSCIENCE
    61. Gregoire, C; Marco, S; Thimonier, J; Duplan, L; Laurine, E; Chauvin, JP; Michel, B; Peyrot, V; Verdier, JM
      Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease

      EMBO JOURNAL
    62. Buervenich, S; Olson, L; Galter, D
      Nestin-like immunoreactivity of corpora amylacea in aged human brain

      MOLECULAR BRAIN RESEARCH
    63. Wirdefeldt, K; Bogdanovic, N; Westerberg, L; Payami, H; Schalling, M; Murdoch, G
      Expression of alpha-synuclein in the human brain: relation to Lewy body disease

      MOLECULAR BRAIN RESEARCH
    64. Kitamura, Y; Sanada, H; Kakimura, J; Ishida, Y; Shimohama, S; Taniguchi, T
      Decrease of tyrosine hydroxylase-, alpha-synuclein- and parkin-expressing neurons in the substantia nigra of MPTP-treated C57BL/6N mice

      BIOGENIC AMINES
    65. Shastry, BS
      Parkinson disease: etiology, pathogenesis and future of gene therapy

      NEUROSCIENCE RESEARCH
    66. Albers, DS; Augood, SJ
      New insights into progressive supranuclear palsy

      TRENDS IN NEUROSCIENCES
    67. Chung, KKK; Dawson, VL; Dawson, TM
      The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders

      TRENDS IN NEUROSCIENCES
    68. Vila, M; Wu, DC; Przedborski, S
      Engineered modeling and them secrets of Parkinson's' disease

      TRENDS IN NEUROSCIENCES
    69. Huynh, DP; Dy, M; Nguyen, D; Kiehl, TR; Pulst, SM
      Differential expression and tissue distribution of parkin isoforms during mouse development

      DEVELOPMENTAL BRAIN RESEARCH
    70. Zurn, AD; Widmer, HR; Aebischer, P
      Sustained delivery of GDNF: towards a treatment for Parkinson's disease

      BRAIN RESEARCH REVIEWS
    71. Spillantini, MG; Goedert, M
      Tau and Parkinson disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    72. Imai, Y; Soda, M; Inoue, H; Hattori, N; Mizuno, Y; Takahashi, R
      An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin

      CELL
    73. Rajagopalan, S; Andersen, JK
      Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?

      MECHANISMS OF AGEING AND DEVELOPMENT
    74. Haass, C; Kahle, PJ
      Neuroscience - Parkin and its substrates

      SCIENCE
    75. Prusiner, SB
      Shattuck lecture - Neurodegenerative diseases and prions.

      NEW ENGLAND JOURNAL OF MEDICINE
    76. Tsuboi, Y; Ahlskog, JE; Apaydin, H; Parisi, JE; Dickson, DW
      Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

      NEUROLOGY
    77. Terreni, L; Calabrese, E; Calella, AM; Forloni, G; Mariani, C
      New mutation (RA2P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism

      NEUROLOGY
    78. Kruger, R; Kuhn, W; Leenders, KL; Sprengelmeyer, R; Muller, T; Woitalla, D; Portman, AT; Maguire, RP; Veenma, L; Schroder, U; Schols, L; Epplen, JT; Riess, O; Przuntek, H
      Familial parkinsonism with synuclein pathology - Clinical and PET studies of A30P mutation carriers

      NEUROLOGY
    79. Payami, H; Lee, N; Zareparsi, S; McNeal, MG; Camicioli, R; Bird, TD; Sexton, G; Gancher, S; Kaye, J; Calhoun, D; Swanson, PD; Nutt, J
      Parkinson's disease, CYP2D6 polymorphism, and age

      NEUROLOGY
    80. Masliah, E; Rockenstein, E; Veinbergs, I; Sagara, Y; Mallory, M; Hashimoto, M; Mucke, L
      beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    81. Munoz, E; Pastor, P; Marti, MJ; Valldeoriola, F; Oliva, R; Tolosa, E
      Sporadic and familiar Parkinson's disease: comparative study

      MEDICINA CLINICA
    82. Berciano, J
      Genetics in Parkinson's disease: toward a new nosological era

      MEDICINA CLINICA
    83. Behari, M; Srivastava, AK; Das, RR; Pandey, RM
      Risk factors of Parkinson's disease in Indian patients

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    84. Akhmedova, SN; Yakimovsky, AK; Schwartz, EI
      Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    85. Togo, T; Iseki, E; Marui, W; Akiyama, H; Ueda, K; Kosaka, K
      Glial involvement in the degeneration process of Lewy body-bearing neuronsand the degradation process of Lewy bodies in brains of dementia with Lewybodies

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    86. Tomidokoro, Y; Harigaya, Y; Matsubara, E; Ikeda, M; Kawarabayashi, T; Shirao, T; Ishiguro, K; Okamoto, K; Younkin, SG; Shoji, M
      Brain A beta amyloidosis in APPsw mice induces accumulation of presenilin-I and tau

      JOURNAL OF PATHOLOGY
    87. McShane, RH; Nagy, Z; Esiri, MM; King, E; Joachim, C; Sullivan, N; Smith, AD
      Anosmia in dementia is associated with Lewy bodies rather than Alzheimer'spathology

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    88. Papapetropoulos, S; Paschalis, C; Athanassiadou, A; Papadimitriou, A; Ellul, J; Polymeropoulos, MH; Papapetropoulos, T
      Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    89. Berg, D; Gerlach, M; Youdim, MBH; Double, KL; Zecca, L; Riederer, P; Becker, G
      Brain iron pathways and their relevance to Parkinson's disease

      JOURNAL OF NEUROCHEMISTRY
    90. West, A; Farrer, M; Petrucelli, L; Cookson, M; Lockhart, P; Hardy, J
      Identification and characterization of the human parkin gene promoter

      JOURNAL OF NEUROCHEMISTRY
    91. Rideout, HJ; Larsen, KE; Sulzer, D; Stefanis, L
      Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells

      JOURNAL OF NEUROCHEMISTRY
    92. Bodles, AM; Guthrie, DJS; Greer, B; Irvine, GB
      Identification of the region of non-A beta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

      JOURNAL OF NEUROCHEMISTRY
    93. Kubo, S; Kitami, T; Noda, S; Shimura, H; Uchiyama, Y; Asakawa, S; Minoshima, S; Shimizu, N; Mizuno, Y; Hattori, N
      Parkin is associated with cellular vesicles

      JOURNAL OF NEUROCHEMISTRY
    94. Kawamata, H; McLean, PJ; Sharma, N; Hyman, BT
      Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations

      JOURNAL OF NEUROCHEMISTRY
    95. Iwata, A; Miura, S; Kanazawa, I; Sawada, M; Nukina, N
      alpha-synuclein forms a complex with transcription factor Elk-1

      JOURNAL OF NEUROCHEMISTRY
    96. Lee, M; Hyun, DH; Halliwell, B; Jenner, P
      Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

      JOURNAL OF NEUROCHEMISTRY
    97. Stefanis, L; Kholodilov, N; Rideout, HJ; Burke, RE; Greene, LA
      Synuclein-1 is selectively up-regulated in response to nerve growth factortreatment in PC12 cells

      JOURNAL OF NEUROCHEMISTRY
    98. Campbell, BCV; McLean, CA; Culvenor, JG; Gai, WP; Blumbergs, PC; Jakala, P; Beyreuther, K; Masters, CL; Li, QX
      The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

      JOURNAL OF NEUROCHEMISTRY
    99. Kad, NM; Thomson, NH; Smith, DP; Smith, DA; Radford, SE
      beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro

      JOURNAL OF MOLECULAR BIOLOGY
    100. Kirkitadze, MD; Condron, MM; Teplow, DB
      Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis

      JOURNAL OF MOLECULAR BIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 10:33:48